معرفی
Mette Homann Poulsen serves as an Assistant Professor in the Department of Drug Design and Pharmacology at the University of Copenhagen, with additional affiliation as a Guest Researcher in the Biopharmaceuticals section of the same department. Her research bridges molecular pharmacology and drug design with a focus on ion channel mechanisms.
Her primary research interests span Ion Channel Pharmacology, Receptor Biology, and Molecular Pharmacology, particularly investigating P2X and AMPA receptor families. Her work examines pH-sensing mechanisms, transporter-channel crosstalk, and receptor variants in disease contexts including cancer and mental disorders. She employs techniques ranging from protein engineering to cellular electrophysiology to develop pharmacological tools and understand disease mechanisms.
Analysis of her recent publications (2018-2025) reveals a strong emphasis on receptor variant functionality, with significant contributions to understanding P2X7 receptor polymorphisms in pancreatic cancer and mental health disorders. Her work integrates biophysical approaches with disease modeling, demonstrating translational potential in oncology and neuroscience.
No scientific awards were explicitly mentioned in the source material.
Dr. Poulsen maintains active collaborations with researchers including S.A. Pless, N.R. Jørgensen, and I. Novak across multiple institutions. Her research has attracted substantial attention, with publications generating significant Mendeley readership and social media engagement, particularly her 2020 Nature Communications paper which garnered 117 Mendeley readers and 17 social media interactions.
While specific laboratory or team structures weren't detailed in the source material, her publication patterns suggest active participation in interdisciplinary research groups focusing on receptor pharmacology and protein engineering within the Department of Drug Design and Pharmacology.
